Some patients who undergo selective internal radiotherapy (SIRT) with yttrium-90 (Y-90) may be eligible for liver resection, researchers reported. | Read More
Researchers have identified factors that are linked with increased risk of symptomatic recurrence after radiofrequency ablation for osteoid osteomas. | Read More
The Society of Interventional Oncology (SIO) recently sent a letter to the National Comprehensive Cancer Network (NCCN) Kidney Cancer Guideline panel seeking changes to proposed guidelines for management of T1a renal masses. | Read More
In an abstracted presented at SIR, researchers evaluated whether transarterial Y-90 radioembolization with resin microspheres using MIRD dosimetry for intrahepatic cholangiocarcinoma is safe and effective. | Read More
Patients with metastatic neuroendocrine tumors may potentially be able to consider same-day mapping or no mapping prior to treatment with Y-90 radioembolization, according to an abstract presented at SIR. | Read More

Spotlight

Alda Tam, MD, presents the case of a 60-year-old man with mesothelioma.
Robert Lewandowski, MD, an interventional radiologist and Director of Interventional Oncology at Northwestern University Feinberg School of Medicine in Chicago, describes the rationale for radiation lobectomy, as well as recent advances and practical tips.
Dan Brown, MD, shows case examples demonstrating timing of Y-90 therapy and personalizing therapy to the patient's biology.